Live Breaking News & Updates on Rachel Pessah Pollack

Stay updated with breaking news from Rachel pessah pollack. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Are Secondary Osteoporosis Causes Under-Investigated?

A single-center chart review found that postmenopausal women with osteoporosis may be started on antiresorptive therapy without having had secondary causes ruled out. ....

New York University , New York , United States , Sankt Peterburg , Sheetal Bulchandani , Kajol Manglani , Rachel Pessah , Endocrine Society , Georgetown University Medstar Washington Hospital Center , American College Of Endocrinology , Georgetown University Medstar Washington Hospital , Holman Division Of Endocrinology , American Association Of Clinical Endocrinology , American Association Of Clinical Endocrinologists , American Association , Clinical Endocrinologists , Medstar Washington Hospital Center , Clinical Endocrinology , Annual Meeting , Medscape Medical News , Medstar Washington Hospital , Rachel Pessah Pollack , Holman Division , New York University School , New York City , American College ,

GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin

Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin. ....

South Korea , New York , United States , Rachel Pessah , Dulaglutide Trulicity , Epic Research , University Of North Carolina At Chapel Hill , Novo Nordisk , While The Epic Research , North Carolina , Chapel Hill , Medscape Medical News , Rachel Pessah Pollack , Ambulatory Care , Lake Success , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Thyroid Disorder , Malignant Head And Neck Neoplasm , Thyroid Cancer , Thyroid Carcinoma , Ancer Of The Thyroid , Medullary Thyroid Carcinoma , Edullary Carcinoma Of The Thyroid , Glp 1 Receptor Agonists ,